http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105218660-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate | 2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105218660-B |
| titleOfInvention | The novel purification renaturation method and its antitumor application thereof of Recombinant Endostatin |
| abstract | The present invention relates to the novel purification renaturation methods and its antitumor application thereof of Recombinant Endostatin.The renaturation and purification process of a kind of new recombinant human endothelial cell amicine inclusion body are disclosed for the first time.Method of the invention can low in cost, yield highland obtain the rhED albumen of purifying, bioactivity is excellent, and drug effect is significant. |
| priorityDate | 2014-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.